MONTREAL, QUEBEC--(Marketwired - Jan. 21, 2016) - ZoomMed inc. (TSX VENTURE:ZMD) announces that during its Board of directors held on January 15, 2016, the Board agreed to grant options allows its holder to purchase one common share of ZoomMed at a price of twenty one cents ($0.21).

600,000 stock options have been grant to its directors and officers and 500,000 stock options to its employees and consultants, for a total of 1,100,000 options and taking effect on January 21, 2016. These options are valid for a five (5) year period following their issuance, subject to the provisions of the stock option plan of ZoomMed and TSX Venture Exchange policies.

For further information on ZoomMed, visit our Web Site;

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Statements made in this news release that are not historical facts are "forward-looking statements" and readers are cautioned that any such statements are not guarantees of future performance, and that actual developments or results, may vary materially from those in these "forward-looking" statements.

Contact Information:

ZoomMed Inc.
Mr. Yves Marmet
President and Chief Executive Officer
(450) 678-5457, Ext 228